2.0
24 Jan 2024
Current employee, more than 3 years
London, England
Recommend
CEO approval
Business outlook
Pros
Benefits are ok, as is salary. Generally colleagues are helpful and nice.
Cons
We have major pharma companies starting to leave due to very poor management. All processes are a mess and difficult to navigate. They need to reconsider the strategy and invest in unified systems. Staff turnover is high.